Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): A multicentre randomised, double blind, placebo controlled trial (PEARL trial)

K de Wit, JJ Schaapman, F Nevens, J (Jos) Verbeek, Sandra Coenen, FJC Cuperus, M de Kramer, ET Tjwa, N Mostafavi, MG Dijkgraaf, OM van Delden, UHW Beuers, MJ Coenraad, RB Takkenberg

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
12 Downloads (Pure)
Original languageEnglish
Article numbere000531
JournalBMJ Open Gastroenterology
Issue number1
Publication statusPublished - 2020

Research programs

  • EMC MM-04-20-01
  • EMC ONWAR-01-58-02

Cite this